{"nct_id":"NCT02642159","title":"Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2016-03-15","start_date_type":null,"primary_completion_date":"2017-03-22","primary_completion_date_type":"ACTUAL","completion_date":"2017-05-15","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["SNY"]}